Investor FAQs

Investor FAQs

Show all

Please contact Stephen Kilmer, Investor Relations, Phone: (678) 270-3631, Email: stephen.kilmer@clearsidebio.com

Please visit http://ir.clearsidebio.com/shareholder-services/email-alerts to be added to the Clearside Biomedical distribution list.

900 North Point Parkway, Suite 200, Alpharetta, GA 30005
 
Delaware
June 1, 2016
January 1 – December 31
The NASDAQ Global Market under the symbol “CLSD”
We have never declared or paid any dividends on our common stock. We anticipate that we will retain all of our future earnings, if any, for use in the operation and expansion of our business and do not anticipate paying cash dividends in the foreseeable future.
American Stock Transfer & Trust Company. You can find more information at https://www.amstock.com
Contact our transfer agent, American Stock Transfer & Trust Company at https://www.amstock.com/shareholder/sh_faqs.asp. They can look up your records and make any necessary adjustments. There is a fee involved for replacing lost certificates.
Clearside Biomedical does not offer a direct stock purchase plan.
Ernst & Young LLP

Let’s get the conversation going

Questions? We’d love to hear from you.

REQUEST INFORMATION

Investor Menu